Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Appointed director
SANGAMO THERAPEUTICS, INC (SGMO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 8-K Quarterly results
Docs: "SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND SECOND QUARTER 2023 FINANCIAL RESULTS"
02/22/2023 8-K Quarterly results
Docs: "SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS"
08/04/2022 8-K Quarterly results
Docs: "SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND SECOND QUARTER 2022 FINANCIAL RESULTS"
05/05/2022 8-K Quarterly results
02/24/2022 8-K Quarterly results
11/04/2021 8-K Quarterly results
Docs: "SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS AND CLINICAL HIGHLIGHTS AND THIRD QUARTER 2021 FINANCIAL RESULTS"
08/05/2021 8-K Quarterly results
Docs: "SANGAMO THERAPEUTICS REPORTS RECENT BUSINESS HIGHLIGHTS AND SECOND QUARTER 2021 FINANCIAL RESULTS"
05/04/2021 8-K Quarterly results
02/24/2021 8-K Quarterly results
11/04/2020 8-K Quarterly results
Docs: "SANGAMO THERAPEUTICS REPORTS BUSINESS HIGHLIGHTS AND THIRD QUARTER 2020 FINANCIAL RESULTS"
08/05/2020 8-K Quarterly results
05/11/2020 8-K Quarterly results
02/28/2020 8-K Quarterly results
11/06/2019 8-K Quarterly results
Docs: "Sangamo Therapeutics reports third QUARTER 2019 Financial Results Conference Call and Webcast Scheduled for 5:00 p.m. Eastern Time"
08/07/2019 8-K Quarterly results
05/08/2019 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : May 3, 2019 SANGAMO THERAPEUTICS, INC. Delaware 000-30171 68-0359556 501 Canal Blvd., Richmond, California 94804 970-6000 Not Applicable Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act ☐ Pre-commencement communications pursuant to Rule 14d-2 under the Exchange Act ) ☐ Pre-commencement communications pursuant to Rule 13e-4 under...",
"SANGAMO THERAPEUTICS REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS"
02/28/2019 8-K Quarterly results
11/08/2018 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15 of the Securities Exchange Act of 1934 Date of Report : November 8, 2018 SANGAMO THERAPEUTICS, INC. Delaware 000-30171 68-0359556 501 Canal Blvd., Richmond, California 94804 970-6000 Not Applicable",
"SANGAMO THERAPEUTICS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS"
08/08/2018 8-K Quarterly results
Docs: "SANGAMO THERAPEUTICS REPORTS SECOND QUARTER 2018 FINANCIAL RESULTS"
05/08/2018 8-K Quarterly results
Docs: "Sangamo Therapeutics reports first QUARTER 2018 Financial Results Conference Call and Webcast Scheduled for 8:00 a.m. Eastern Time Today"
02/22/2018 8-K Quarterly results
Docs: "SANGAMO THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS",
"Joint Release"
11/09/2017 8-K Quarterly results
Docs: "SANGAMO THERAPEUTICS REPORTS THIRD QUARTER 2017 FINANCIAL RESULTS"
08/09/2017 8-K Quarterly results
05/10/2017 8-K Form 8-K - Current report
02/28/2017 8-K Form 8-K - Current report
10/26/2016 8-K Quarterly results
Docs: "Exhibit 99.1 Sangamo BioSciences Reports Third Quarter 2016 Financial Results"
08/03/2016 8-K Form 8-K - Current report
05/02/2016 8-K Form 8-K - Current report
10/28/2015 8-K Quarterly results
Docs: "Exhibit 99.1 Sangamo BioSciences Reports Third Quarter 2015 Financial Results"
08/05/2015 8-K Quarterly results
Docs: "Sangamo BioSciences Reports Second Quarter 2015 Financial Results"
04/22/2015 8-K Quarterly results
Docs: "Sangamo BioSciences Reports First Quarter 2015 Financial Results"
10/22/2014 8-K Quarterly results
Docs: "Sangamo BioSciences Reports Third Quarter 2014 Financial Results"
07/23/2014 8-K Quarterly results
Docs: "Sangamo BioSciences Reports Second Quarter 2014 Financial Results"
05/06/2014 8-K Quarterly results
Docs: "Sangamo BioSciences Reports First Quarter 2014 Financial Results"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy